ofloxacin and Colorectal Cancer

ofloxacin has been researched along with Colorectal Cancer in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Capelo-Martínez, JL; Cruz, MM; Duarte, MP; Galhano, J; Lodeiro, C; Marcelo, GA; Marcos, MD; Martínez-Máñez, R; Oliveira, E; Robalo, TT	1
Bolaños Rivero, M; Lorenzo Garde, L; Martín Sánchez, AM; Turégano García, Á	1
Fischbach, W; Flieger, D; Hainke, S; Keller, R; Klassert, C; Kleinschmidt, R	1

Trials

1 trial(s) available for ofloxacin and Colorectal Cancer

Article	Year
Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma. Oncology, 2007, Volume: 72, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Camptothecin; Cholestyramine Resin; Colorectal Neoplasms; Diarrhea; Female; Humans; Irinotecan; Levofloxacin; Male; Middle Aged; Ofloxacin; Time Factors	2007

Article

Year

Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma.

Oncology, 2007, Volume: 72, Issue:1-2

Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Camptothecin; Cholestyramine Resin; Colorectal Neoplasms; Diarrhea; Female; Humans; Irinotecan; Levofloxacin; Male; Middle Aged; Ofloxacin; Time Factors

2007

Other Studies

2 other study(ies) available for ofloxacin and Colorectal Cancer

Article	Year
Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer. International journal of molecular sciences, 2022, Oct-14, Volume: 23, Issue:20 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Colorectal Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hyperthermia, Induced; Nanoparticles; Ofloxacin; Porosity; Silicon Dioxide	2022
[Intraperitoneal abscess for Eikenella corrodens]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2011, Volume: 24, Issue:2 Topics: Abdominal Abscess; Adenocarcinoma; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Colorectal Neoplasms; Eikenella corrodens; Female; Gram-Negative Bacterial Infections; Haemophilus Infections; Hernia, Ventral; Humans; Intestinal Obstruction; Intestine, Small; Intraoperative Complications; Ofloxacin; Streptococcal Infections; Surgical Wound Infection; Tissue Adhesions	2011

Article

Year

Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer.

International journal of molecular sciences, 2022, Oct-14, Volume: 23, Issue:20

Topics: Anti-Bacterial Agents; Anti-Infective Agents; Colorectal Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hyperthermia, Induced; Nanoparticles; Ofloxacin; Porosity; Silicon Dioxide

2022

[Intraperitoneal abscess for Eikenella corrodens].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2011, Volume: 24, Issue:2

Topics: Abdominal Abscess; Adenocarcinoma; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Colorectal Neoplasms; Eikenella corrodens; Female; Gram-Negative Bacterial Infections; Haemophilus Infections; Hernia, Ventral; Humans; Intestinal Obstruction; Intestine, Small; Intraoperative Complications; Ofloxacin; Streptococcal Infections; Surgical Wound Infection; Tissue Adhesions

2011